Compliance Scorecard: Chemical/Pharmaceutical

Five regulations that security executives in this sector need to know

The FCPA makes it illegal for U.S. companies to pay foreign officials for the purpose of obtaining or keeping business. The pharmaceutical industry has been particularly impacted by this law because the term “foreign officials” has been noted to include employees of state-owned hospitals abroad. Pharmaceutical companies who pay the travel expenses or meal tabs for foreign doctors in socialized medical systems are therefore in potential violation of FCPA anti-bribery provisions. On June 14, the U.S. House Judiciary Committee held a hearing on FCPA at which Rep. Jim Sensenbrenner (R- Wis.) announced he would draft legislation to amend the Act to, among other actions, narrow the definition of “foreign officials.” Draft legislation was not available at the time of this writing.

 The Security Executive Council ( is an innovative problem-solving research and services organization. We work with Tier 1 Security Leaders to reduce risk and add to corporate profitability in the process. A faculty of more than 100 experienced security executives provides strategy, insight and proven practices that cannot be found anywhere else. The Council is building the fastest-growing repository of proven resources to help you manage risk. Visit our resource page on security regulation and compliance issues: